• Flu Home

• Flu Symptoms
• Prevention and Treatment
• Questions & Answers

 

Providers

General guidance for H3N2v remains the same as that for seasonal influenza. H3N2v-specific guidance will be added below as it becomes available.

Resources/Tools

• Novel Avian Influenza A (H7N9) Virus Infections: Update for Clinicians (893 KB PDF)
  • CDC Updates for Avian Influenza A (H7N9)
  • WHO Updates for Avian Influenza A (H7N9)
• Influenza A H3N2v Virus Infections: Update for Clinicians (152 KB PDF)
• 2012–13 Influenza Season: Update for NC Clinicians (185 KB PDF)

Influenza Vaccine 2012-13

• Vaccine Recommendations, Supplies, and Resources

Infection Control

• Infection Control Guidance for Clinicians (181 KB PDF)
• Guidance on Prevention of Influenza Virus Infections in Long-Term Care Facilities - CDC (Sept 2010)
• CDC Guidance on Prevention Strategies for Seasonal Influenza in Healthcare Settings - CDC (Sept 2010)
• Home Respiratory Isolation: Instructions for Patients, N.C. DPH (101 KB PDF)

Specimen Collection & Testing

• Criteria for Testing by the North Carolina State Laboratory for Public Health (157 KB PDF)
• Specimen Collection for Influenza Testing at the North Carolina State Laboratory for Public Health, 10/14/11 - N.C. DPH (245 KB PDF)
• Antiviral Resistance Testing

Surveillance and Tracking

• Surveillance and Tracking Guidance for Clinicians (158 KB PDF)
• North Carolina's Weekly Influenza Surveillance Report
• CDC's Weekly Influenza Surveillance Report

Treatment

• NEW! CDC Health Advisory – Influenza Antiviral Medications (301 KB PDF)
• Treatment Guidance for Clinicians (187 KB PDF)
• Use of Antivirals - CDC (Aug 2011)
• Intravenous (IV) Zanamivir Information (80 KB PDF)
• Intravenous (IV) Peramivir Information (28 KB PDF)